Pfizer, the pharma giant, also makes the news as a law department

Almost as ubiquitous as little blue pills are posts on this blog about the world’s largest pharmaceutical company.

Here they are about Pfizer in chronological order (See my post of Oct.1, 2005: Laura Kibbe and internal discovery team; Feb. 14, 2007: standard for handling litigation documents; Feb. 25, 2007: secondees; March 3, 2007: its products-liability panel; March 12, 2007: Pfizer’s Partnering Program; March 13, 2007: Pfizer’s P3 pain [two posts]; May 26, 2007: CEO was its previous general counsel; Dec. 12, 2007: data warehouse; March 20, 2008: interim GC appointed after Alan Waxman resigned; June 11, 2008 #4: Kibbe decamps; Sept. 12, 2008: transitioning cases to new firm; Sept. 12, 2008: detailed article on Pfizer’s RFP process; Dec. 11, 2008: diversity initiative; Dec. 14, 2008: diversity conference for firms; Feb. 16, 2009: uses decision tree analysis; Aug. 5, 2009: evaluations of law firms; Aug. 13, 2009: tiered discounts; Aug. 28, 2009: requires value reports from firms; Jan. 12, 2010: three firms band together to serve it; and Jan. 12, 2010: some questions about its huge fixed-fee arrangement.).